Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

India Coronavirus Actions: Stock Checks, Kaletra Gx Readiness And Bulk Drugs

Mar 17 2020

• By Anju Ghangurde

India — India Takes Host Of Measures To Tackle Coronavirus-Related Supply Issues • Source: Shutterstock

Related Content

India Curbs Exports Amid Coronavirus

Mar 04 2020

India Export Restrictions: Balancing Tweaks In Store?

Mar 10 2020

Sanofi To Test Arthritis Drug Kevzara For Coronavirus

Mar 11 2020

India Acts To Limit Supply Disruption From Coronavirus

Feb 25 2020

Sanofi And Regeneron Initiate 400-Patient Coronavirus Trial With Kevzara

Mar 16 2020

China Taps Roche Antibody, Green Lights Testing Kits For Coronavirus Arsenal

Mar 05 2020

IPA Chief Reddy: Coronavirus API Supply Impact A ‘Big Wake Up Call’ For India

Mar 06 2020

Roche Primes New Push Via Cipla For Avastin, Actemra In India

Feb 28 2018

Related Companies

AbbVie Inc.

Cipla Limited

Aurobindo Pharma Limited

Sun Pharmaceutical Industries Ltd.

Viatris Inc.

Emcure Pharmaceuticals Pvt Ltd.

Sanofi

Regeneron Pharmaceuticals, Inc.

Abbott

Roche Holding AG

Dr. Reddy's Laboratories Ltd.

Additional Topics

India Asia Pacific Coronavirus COVID-19 Generic Drugs BioPharmaceutical

More from COVID-19

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window